Impaired Sequential Working Memory in Patients With Young Onset Parkinson's Disease
Brain and Behavior · 2024
DOI: 10.1002/brb3.70182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Guanyu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: China Institute of Sport Science, Beijing, China. Hauptthemen laut MEDLINE: Parkinson Disease, Memory, Short-Term, Age of Onset. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the China Institute of Sport Science, the National Key Research and Development Program of China: BTIT, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Sequential working memory refers to the cognitive ability to maintain and/or manipulate a set of ordered representations within a short period. It remains unclear whether sequential working memory is impaired in patients with young onset Parkinson's disease (YOPD).
Objectives
The aim of this study is to evaluate the sequential working memory in patients with YOPD.
Methods
Sixty‐three YOPD patients (29 women) and one hundred age‐ and education‐matched healthy controls participated in three well‐established sequential working memory tests. The YOPD patients were categorized into akinetic rigid type (PD‐ART) and non‐akinetic rigid type (PD‐NART). Participants were asked to maintain digit sequences in mind in the digit span forward (DST‐F) and to maintain and manipulate digit sequences in mind in the digit span backward (DST‐B) and adaptive digit ordering tests (DOT‐A).
Results
The PD‐ART group scored lower and had higher ordering costs (difference between the DST‐F and DOT‐A scores) than the healthy control group in the DOT‐A. Moreover, in the PD‐ART group, the daily levodopa equivalent dose for dopamine D2/3 receptor agonists positively correlated with the DOT‐A score and negatively correlated with the DOT‐A ordering cost, suggesting that patients who took a greater dose of dopamine D2/3 receptor agonists tended to have higher DOT‐A scores and lower DOT‐A ordering costs.
Conclusions
These results indicated that the impaired sequential working memory may be one of markers of identifying early cognitive impairment in patients with YOPD, especially in PD‐ART patients. The dopamine D2/3 receptor agonists can recover this impairment to some extent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- China Institute of Sport Science, Beijing, China.
- Department of Neurology, Taian Hospital of Traditional Chinese Medicine, Taian, China.
- Department of Geriatrics Center, The Fourth People's Hospital of Shenyang, Shenyang, China.
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Department of Neurobiology, Neurology and Geriatrics, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Institute of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
ORCID-Profile: Guanyu Zhang
Förderung
- the Fundamental Research Funds for the China Institute of Sport Science
- the National Key Research and Development Program of China: BTIT
- National Key Research and Development Program of China
Zitieren
APA
Zhang, G., Zhang, S., Zhao, Z., Ma, J., Chan, P., & Ye, Z. (2024). Impaired Sequential Working Memory in Patients With Young Onset Parkinson's Disease. Brain and Behavior. https://doi.org/10.1002/brb3.70182
Vancouver
Zhang G, Zhang S, Zhao Z, Ma J, Chan P, Ye Z. Impaired Sequential Working Memory in Patients With Young Onset Parkinson's Disease. Brain and Behavior. 2024. doi:10.1002/brb3.70182
BibTeX
@article{Zhang2024,
author = {Zhang, Guanyu and Zhang, Shuo and Zhao, Zhenzhen and Ma, Jinghong and Chan, Piu and Ye, Zheng},
title = {Impaired Sequential Working Memory in Patients With Young Onset Parkinson's Disease},
journal = {Brain and Behavior},
year = {2024},
doi = {10.1002/brb3.70182}
}
EUVIMED